AR043118A1 - PIRIMIDINE DERIVATIVES FOR THE PREVENTION OF HIV INFECTION - Google Patents

PIRIMIDINE DERIVATIVES FOR THE PREVENTION OF HIV INFECTION

Info

Publication number
AR043118A1
AR043118A1 ARP040100383A ARP040100383A AR043118A1 AR 043118 A1 AR043118 A1 AR 043118A1 AR P040100383 A ARP040100383 A AR P040100383A AR P040100383 A ARP040100383 A AR P040100383A AR 043118 A1 AR043118 A1 AR 043118A1
Authority
AR
Argentina
Prior art keywords
alkyl
substituted
alkyloxycarbonyl
alkylcarbonyl
amino
Prior art date
Application number
ARP040100383A
Other languages
Spanish (es)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of AR043118A1 publication Critical patent/AR043118A1/en

Links

Abstract

Uso de un compuesto para la manufactura de un medicamento para la prevención de una infección por HIV por relaciones sexuales o contacto íntimo en la pareja, en donde el compuesto es un compuesto de la fórmula (1) un N-óxido, una sal de adición farmacéuticamente aceptable, una amina cuaternaria y una forma estereoquímicamente isomérica del mismo, donde el anillo que contiene -a1=a2-a3=a4-, y -b1=b2-b3=b4-, representa fenilo, piridilo, pirimidinilo, pirazinilo, piridazinilo; n es 0 a 5, m es 1 a 4; R1 es H, arilo, formilo, alquilcarbonilo C1-6, alquilo C1-6, alquiloxicarbonilo C1-6, alquilo C1-6 sustituido, alquilcarbonilo C1-6, alquiloxicarbonilo C1-6, alquilcarboniloxi C1-6, alquiloxi C1-6alquilcarbonilo C1-6 sustituido; R2 es hidroxi, halo, alquilo C1-6 opcionalmente sustituido, cicloalquilo C3-7, alquenilo C2-6 opcionalmente sustituido, alquinilo C2-6 opcionalmente sustituido, alquiloxi C1-6, alquiloxicarbonilo C1-6, carboxilo, ciano, nitro, amino, mono- o di(alquilo C1-6 amino), polihalometilo, polihalometiloxi, polihalometiltio, -S(=O)pR6, -NH-S(=O)pR6, -C(=O)R6, -NHC(=O)H, -C(=O)NHNH2, -NHC(=O)R6, -C(=NH)R6 o un heterociclo de 5 miembros; X1 es -NR5-, -NH-NH-, -N=N-, -O-, -C(=O)-, alcanodiilo C1-4, -CHOH-, -S-, -S(=O)p-, -X2-alcanodiilo C1-4 o alcanodiilo C1-4-X2-; R3 es NHR13, NR13R14; -C(=O)-NHR13-, -C(=O)-NR13R14-, -C(=O)-R15, -CH=N-NH-C(=O)-R16, alquilo C1-6 sustituido; alquiloxi C1-6alquilo C1-6 opcionalmente sustituido; alquenilo C2-6 sustituido; alquinilo C2-6 sustituido, alquilo C1-6 sustituido con hidroxi y un segundo sustituyentes, -C(=N-O-R8)-alquilo C1-4; R7, o -X3-R7; R4 es halo, hidroxi, alquilo C1-6, cicloalquilo C3-7, alquiloxi C1-6, ciano, nitro, polihaloalquilo C1-6, polihaloalquiloxi C1-6, aminocarbonilo, alquiloxicarbonilo C1-6, alquilcarbonilo C1-6, formilo, amino, mono- o di-(alquilo C1-4)amino, y composiciones farmacéuticas que los comprenden.Use of a compound for the manufacture of a medicament for the prevention of HIV infection by sexual intercourse or intimate contact in the couple, wherein the compound is a compound of the formula (1) an N-oxide, an addition salt pharmaceutically acceptable, a quaternary amine and a stereochemically isomeric form thereof, where the ring containing -a1 = a2-a3 = a4-, and -b1 = b2-b3 = b4-, represents phenyl, pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl ; n is 0 to 5, m is 1 to 4; R 1 is H, aryl, formyl, C 1-6 alkylcarbonyl, C 1-6 alkyl, C 1-6 alkyloxycarbonyl, substituted C 1-6 alkyl, C 1-6 alkylcarbonyl, C 1-6 alkyloxycarbonyl, C 1-6 alkylcarbonyloxy, C 1-6 alkyloxyC 1-6 alkylcarbonyl 6 substituted; R2 is hydroxy, halo, optionally substituted C1-6 alkyl, C3-7 cycloalkyl, optionally substituted C2-6 alkenyl, optionally substituted C2-6 alkynyl, C1-6 alkyloxy, C1-6 alkyloxycarbonyl, carboxyl, cyano, nitro, amino, mono- or di (C1-6 amino alkyl), polyhalomethyl, polyhalomethyloxy, polyhalomethylthio, -S (= O) pR6, -NH-S (= O) pR6, -C (= O) R6, -NHC (= O) H, -C (= O) NHNH2, -NHC (= O) R6, -C (= NH) R6 or a 5-membered heterocycle; X1 is -NR5-, -NH-NH-, -N = N-, -O-, -C (= O) -, C1-4 alkanediyl, -CHOH-, -S-, -S (= O) p -, -X2-C1-4 alkanediyl or C1-4 alkanediyl; R3 is NHR13, NR13R14; -C (= O) -NHR13-, -C (= O) -NR13R14-, -C (= O) -R15, -CH = N-NH-C (= O) -R16, substituted C1-6 alkyl; optionally substituted C1-6 alkyloxyC 1-6 alkyl; C2-6 substituted alkenyl; C2-6 alkynyl substituted, C1-6 alkyl substituted with hydroxy and a second substituents, -C (= N-O-R8) -C 1-4 alkyl; R7, or -X3-R7; R4 is halo, hydroxy, C1-6 alkyl, C3-7 cycloalkyl, C1-6 alkyloxy, cyano, nitro, C1-6 polyhaloalkyl, C1-6 polyhaloalkyloxy, aminocarbonyl, C1-6 alkyloxycarbonyl, C1-6 alkylcarbonyl, formyl, amino , mono- or di- (C1-4 alkyl) amino, and pharmaceutical compositions comprising them.

ARP040100383A 2003-02-07 2004-02-06 PIRIMIDINE DERIVATIVES FOR THE PREVENTION OF HIV INFECTION AR043118A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES0301291 2003-02-07

Publications (1)

Publication Number Publication Date
AR043118A1 true AR043118A1 (en) 2005-07-20

Family

ID=42777980

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040100383A AR043118A1 (en) 2003-02-07 2004-02-06 PIRIMIDINE DERIVATIVES FOR THE PREVENTION OF HIV INFECTION

Country Status (1)

Country Link
AR (1) AR043118A1 (en)

Similar Documents

Publication Publication Date Title
BR122015023612B8 (en) pyrimidine derivative compounds, their use, pharmaceutical composition and product
BRPI0407329A (en) Pyrimidine Derivatives for the Prevention of HIV Infection
NO20054127L (en) HIV-inhibiting 1,2,4-triazines
PE20220931A1 (en) PYRAZOLO[3,4-B]PYRAZINE-TYPE SHP2 PHOSPHATASE INHIBITORS
AR030553A1 (en) USE OF DERIVATIVES OF TIAZOLILO 2,4-DISPOSED FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE PREVENTION OR TREATMENT OF DISEASES MEDIATION THROUGH CYTOKINES, DERIVATIVES OF TIAZOLYLL 2,4-DISPOSED, PHARMACEUTICAL COMPOSITIONS THAT THEY UNDERTAKED
NO974586L (en) New Substituted Biphenyl or Phenylpyridine Compounds, Methods for their Preparation and Pharmaceutical Compositions Containing Them
EA200400615A1 (en) AMIDOV DERIVATIVES AS AN INHIBITORS GLYOGENENSINTAZIN-KINAZ 3-BETA
EA200400616A1 (en) AMINOBENZAMIDE DERIVATIVES AS AN INHIBITOR OF GLYCOGENSYNTASE-KINASE 3β
PE20011166A1 (en) PYRIDINES, PYRIMIDINES, PURINONES, PYRROLOPYRIMIDINONES AND PYRROLOPYRIDINONES AS ANTAGONISTS OF THE CORTICOTROPIN RELEASING FACTOR
EA200100536A1 (en) Pyrimidines that inhibit HIV replication
AR049711A1 (en) HETEROCICLIC COMPOUNDS CONDENSED AS INHIBITORS OF ALDOSTERONE SINTASA; PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OR PREVENTION OF DISEASES RELATED TO HYPERALDOSTERISM AND EXCESSIVE CORTISO RELEASE
PE20030702A1 (en) PDE9 INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS
AR051315A1 (en) PYRIMIDINAS 5-REPLACED HIV INHIBITORS
JP2017537949A5 (en)
AR039540A1 (en) MICROBICIDE COMPOUNDS WITH PIRIMIDINE OR TRIAZINE CONTENT
AR050969A1 (en) 5-HETEROCICLIL PYRIMIDINES HIV INHIBITORS; PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME AS MEDICATIONS
PE20100737A1 (en) NEW COMPOUNDS
PE20011349A1 (en) 1-ARIL-4-OXO-1,4-DIHYDRO-3-QUINOLINE CARBOXAMIDES AS ANTIVIRAL AGENTS
AR054888A1 (en) DERIVATIVES OF QUINOLINA AS ANTIBACTERIAL AGENTS
AR043118A1 (en) PIRIMIDINE DERIVATIVES FOR THE PREVENTION OF HIV INFECTION
AR021137A1 (en) DERIVATIVES OF TRIAZINE 2,4-DISPOSED, USE OF THE SAME TO PREPARE MEDICINES, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, PROCEDURE TO PREPARE THEM, AND PROCEDURE TO PREPARE SUCH DERIVATIVES.
AR033554A1 (en) A COMPOUND DERIVED FROM QUINOLINA, ITS USE, PROCEDURES FOR ITS PREPARATION, AND A MEDICATION THAT INCLUDES IT
CY1125571T1 (en) PYRIMIDINES THAT INHIBIT THE MULTIPLICATION OF HIV
DK1155014T3 (en) New benzimidazole compounds for use as active therapeutic agents, processes for the preparation of these compounds and pharmaceutical compositions comprising them
AR045812A1 (en) PURINE DERIVATIVES THAT INHIBIT HIV REPLICATION

Legal Events

Date Code Title Description
FC Refusal
FC Refusal